Cargando…
Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality
Successful translation of chimeric antigen receptor (CAR) T cell therapy for the treatment of solid tumors has proved to be troublesome, mainly due to the complex tumor microenvironment promoting T cell dysfunction and antigen heterogeneity. Mesothelin (MSLN) has emerged as an attractive target for...
Autores principales: | Schoutrop, Esther, Renken, Stefanie, Micallef Nilsson, Isabella, Hahn, Paula, Poiret, Thomas, Kiessling, Rolf, Wickström, Stina L, Mattsson, Jonas, Magalhaes, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313125/ https://www.ncbi.nlm.nih.gov/pubmed/35898704 http://dx.doi.org/10.1080/2162402X.2022.2093426 |
Ejemplares similares
-
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
por: Schoutrop, Esther, et al.
Publicado: (2023) -
Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress
por: Renken, Stefanie, et al.
Publicado: (2022) -
An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
por: Cooper, Matthew L., et al.
Publicado: (2018) -
Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
por: Kiessling, Adela, et al.
Publicado: (2022) -
Counteracting CAR T cell dysfunction
por: Poorebrahim, Mansour, et al.
Publicado: (2021)